Hypetex (United Kingdom)

Recent papers from Hypetex (United Kingdom)

1. A Debate on the Necessity, Practicality, and Importance of Arterial Occlusion Pressure Usage in Blood Flow Restriction Research and PracticeStrength and conditioning journal · 2026
2. Indirect Comparison of the Efficacy of Zanubrutinib vs Ibrutinib and Acalabrutinib in Treatment-Naive Chronic Lymphocytic Leukemia: 6-Year Follow-UpAdvances in Therapy · 2026
3. Subsequent therapies and time to second progression-free survival events (PFS2) in treatment-naive chronic lymphocytic leukemia/small lymphocytic lymphoma (TN CLL/SLL) previously treated with zanubrutinib (zanu) or bendamustine-rituximab (BR) in SEQUOIA.Journal of Clinical Oncology · 2026
4. A Bio‐Inspired Horned Lizard Optimisation‐Driven Super‐Twisting Sliding Mode Control Framework for High‐Performance Global MPPT in PV Systems Under Multiple Partial Shading PatternsIET Renewable Power Generation · 2026
5. Abstract 5118: In silico discovery of potent small molecule inhibitors targeting the AR N-terminal domain for treating castration-resistant prostate cancerCancer Research · 2026
6. Blockchain and Quantum Technologies for Securing the Global Nuclear Supply Chain: Synergies, Applications, Technical Challenges and OpportunitiesJournal of Critical Infrastructure Policy · 2026
7. Synergizing Public Incentives and Private Capital: A Hybrid RAB‐RBF Framework for Low‐Carbon Energy Infrastructure Access in Low‐ and Middle‐Income CountriesJournal of Critical Infrastructure Policy · 2026
8. An indirect comparison of zanubrutinib vs acalabrutinib plus venetoclax in patients with treatment-naive CLLBlood Advances · 2026
9. Large language models for clinical trials in the Global South: opportunities and ethical challengesAI and Ethics · 2025
10. Sport, business and societySport in Society · 2025
11. Inter‐Turn Fault Diagnosis of Induction Motor Using a Root‐Prony and Fuzzy Logic MethodIET Collaborative Intelligent Manufacturing · 2025